HIV-associated neurocognitive disorder—pathogenesis and prospects for treatment

D Saylor, AM Dickens, N Sacktor, N Haughey… - Nature Reviews …, 2016 - nature.com
In the past two decades, several advancements have improved the care of HIV-infected
individuals. Most importantly, the development and deployment of combination antiretroviral …

HIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment

C Eggers, G Arendt, K Hahn, IW Husstedt… - Journal of …, 2017 - Springer
The modern antiretroviral treatment of human immunodeficiency virus (HIV-1) infection has
considerably lowered the incidence of opportunistic infections. With the exception of the …

HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors

RK Heaton, DR Franklin, RJ Ellis, JA McCutchan… - Journal of …, 2011 - Springer
Combination antiretroviral therapy (CART) has greatly reduced medical morbidity and
mortality with HIV infection, but high rates of HIV-associated neurocognitive disorders …

Controversies in HIV-associated neurocognitive disorders

S Nightingale, A Winston, S Letendre… - The Lancet …, 2014 - thelancet.com
Cross-sectional studies show that around half of individuals infected with HIV-1 have some
degree of cognitive impairment despite the use of antiretroviral drugs. However, prevalence …

Pathways to neuronal injury and apoptosis in HIV-associated dementia

M Kaul, GA Garden, SA Lipton - Nature, 2001 - nature.com
Abstract Human immunodeficiency virus-1 (HIV-1) can induce dementia with alarming
occurrence worldwide. The mechanism remains poorly understood, but discovery in brain of …

Human immunodeficiency virus‐associated neurocognitive disorders: mind the gap

JC McArthur, J Steiner, N Sacktor, A Nath - Annals of neurology, 2010 - Wiley Online Library
Human immunodeficiency virus (HIV)‐associated neurocognitive disorders (HANDs) remain
among the most common disorders in people infected with HIV, even in an era when potent …

The prevalence and incidence of neurocognitive impairment in the HAART era

KR Robertson, M Smurzynski, TD Parsons, K Wu… - Aids, 2007 - journals.lww.com
Objectives: HAART suppresses HIV viral replication and restores immune function. The
effects of HAART on neurological disease are less well understood. The aim of this study …

Neurological complications of HIV infection

JC McArthur, BJ Brew, A Nath - The Lancet Neurology, 2005 - thelancet.com
Cognitive disorders, vacuolar myelopathy, and sensory neuropathies associated with HIV
are the most common disorders in patients with HIV AIDS, and are the focus of this review …

Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance

CM Marra, Y Zhao, DB Clifford, S Letendre, S Evans… - Aids, 2009 - journals.lww.com
Objective: To determine whether antiretroviral regimens with good central nervous system
(CNS) penetration control HIV in cerebrospinal fluid (CSF) and improve cognition. Design …

HIV dementia: an evolving disease

JC McArthur - Journal of neuroimmunology, 2004 - Elsevier
Several advances have led to improvements in the care and prognosis of HIV+ individuals.
The first is an understanding of the direct relationship between HIV replication and …